BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities and Deferred Revenue (Tables)

Accrued Liabilities and Deferred Revenue (Tables)

3 Months Ended

Mar. 31, 2016

Accrued liabilities are comprised of the following (in thousands):

	March 31,		December 31,
	2016		2015
Payroll and benefits	$	2,026	$	2,303
Warranty accrual, current portion		1,087		1,345
Taxes		296		445
Accrued professional services		701		681
Accrued capital lease and warranty obligations - current		168		167
Accrued insurance premium		45		467
Other		206		498
Total accrued liabilities	$	4,529	$	5,906

Changes in Initial Product Warranty Accrual and Expenses Under Initial and Extended Warranties

Changes in the initial product warranty accrual and the expenses incurred under the Company’s initial and extended warranties for the three months ended March 31 are included within accrued liabilities on the Consolidated Balance Sheets and were as follows (in thousands):

	Three Months Ended
	March 31,
	2016			2015
Initial warranty accrual, beginning balance	$	2,188		$	1,449
Provision for estimated warranty cost		61			451
Warranty expenditures		(189	)		(233	)
		2,060			1,667
Less warranty accrual, long-term		973			640
Total warranty accrual, current portion	$	1,087		$	1,027

Components of Deferred Revenue

Deferred revenue is comprised of the following (in thousands):

	March 31,		December 31,
	2016		2015
Undelivered elements (training, installation, and product and support services)	$	1,364	$	1,608
Extended warranty contracts		1,432		1,428
Deferred royalties	$	231		261
Total Deferred Revenue		3,027		3,297
Less long-term amounts:
Deferred royalties	$	112		142
Total Deferred Revenue - Long-Term		112		142
Total Deferred Revenue - Current	$	2,915	$	3,155